NCT01808469View on ClinicalTrials.gov

First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Monoclonal antibody

Trial Locations (1)

2333 CL

Centre for Human Drug Research, Leiden

Sponsors
All Listed Sponsors
lead

Light Chain Bioscience - Novimmune SA

INDUSTRY